Call for Australian manufacturers to supply COVID-19 test kit components
6 April 2020 Are you an Australian manufacturer with the capability to produce inputs for COVID-19 RNA extraction? Do you have support to scale up your production? We want to hear from you. Securing Australia’s COVID-19 testing capacity…
Possible coronavirus drug identified by Monash University scientists
3 April 2020 A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint venture of the University of Melbourne and Royal Melbourne Hospital, has shown that…
Where are we at with developing a vaccine for coronavirus?
3 April 2020 This article is republished from The Conversation under a Creative Commons license. Read the original article. Shutterstock Kylie Quinn, RMIT University and Damian Purcell, The Peter Doherty Institute for Infection and Immunity SARS-CoV-2, the virus…
CSIRO begins testing COVID-19 vaccines
2 April 2020 CSIRO, Australia’s national science agency, has commenced the first stage of testing potential vaccines for COVID-19. The testing, expected to take three months, is underway at CSIRO’s high-containment biosecurity facility, the Australian Animal Health Laboratory…
Impact of COVID-19 on Product Development: Information and Resource from Halloran
2 April 2020 Read the full statement from Halloran here. Halloran has formed a company-wide task force to curate information on the impact to the life science industry due to the current COVID-19 environment. We are leveraging our…
The Pratt Foundation commits $1 million to support clinical trials for COVID-19 treatments
31 March 2020 The Doherty Institute has welcomed a generous commitment of $1 million from Anthony Pratt and The Pratt Foundation, which will be directed towards the Australasian COVID-19 Trial (ASCOT). Led by the Royal Melbourne Hospital’s infectious…
COVID-19: Guidance on clinical trials for institutions, HRECs, researchers and sponsors
31 March 2020 COVID-19: Guidance on clinical trials for institutions, HRECs, researchers and sponsors is a joint statement that reflects the shared views of all state and territory Departments of Health, the Therapeutic Goods Administration (TGA), National Health…
Supporting Business to Retain Jobs – JobKeeper Payment
30 March 2020 The Morrison Government has today introduced a JobKeeper Payment of $1,500 per fortnight, per eligible employee, for up to 6 months. The JobKeeper Payment will start on 30 March 2020, with the first payment to…
Medtronic Shares Ventilation Design Specifications to Accelerate Efforts to Increase Global Ventilator Production
31 March 2020 Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it is publicly sharing the design specifications for the Puritan Bennett™ 560 (PB 560) to enable participants across industries to evaluate options for rapid…
Coronavirus Information & Stimulus Packages – Information for you & your business from Australian & Victorian Governments
29 March 2020 The following summarises information available as at 29 March 2020. More information can be found via the following links: AUSTRALIAN GOVERNMENT: – click here / VICTORIAN STATE GOVERNMENT: – click here Read a BioMelbourne Network…
Bill Ferris, pioneer venture capitalist, appointed Chair of the MRCF
26 March 2020 Pioneer venture capitalist, Bill Ferris, the architect behind the Federal Government’s $500m Biomedical Translation Fund (BTF), has been appointed Chair of the Medical Research Commercialisation Fund (MRCF). Mr Ferris was former Chair of the Garvan…
Supporting sole traders through the effects of Coronavirus (Federal Govt)
27 March 2020 Joint media release with the Minister for Families and Social Services Senator the Hon Anne Ruston. The Morrison Government is expanding the eligibility criteria for JobSeeker Payment to support sole traders and Australians who are…
